Pdt Partners, LLC Cyclerion Therapeutics, Inc. Transaction History

Pdt Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.56 - $2.99 $46,956 - $89,999	-30,100 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.73 - $4.13 $34,944 - $52,864	-12,800 Reduced 29.84%	30,100 $92,000
Q1 2021 May 17, 2021	BUY	$2.69 - $5.12 $49,227 - $93,696	18,300 Added 74.39%	42,900 $120,000
Q3 2020 Nov 16, 2020	BUY	$3.46 - $8.39 $25,368 - $61,515	7,332 Added 42.46%	24,600 $150,000
Q2 2020 Aug 14, 2020	SELL	$2.37 - $7.14 $41,240 - $124,243	-17,401 Reduced 50.19%	17,268 $102,000

Q1 2020 May 15, 2020	BUY	$2.46 - $5.84 $85,285 - $202,466	34,669 New	34,669 $92,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $101M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.